Abbreviations - 2021 Workshop Report
In this guide
In this guide|
ADME |
Absorption, Distribution, Metabolism and Excretion |
|
BfR |
Bundesinstitut für Risikobewertung-The German Federal Institute for Risk Assessment |
|
COT |
Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment |
|
EFSA |
European Food Standards Authority |
|
EMA |
European Medicines Agency |
|
FSA |
Food Standards Agency |
|
GSA |
Global sensitivity analysis |
|
INTEGRA |
Integrated External and Internal Exposure |
|
IPCS |
International Programme on Chemical Safety |
|
IVIVE |
In vitro to in vivo extrapolation |
|
JPMDA |
Japanese Pharmaceuticals and Medical Devices Agency |
|
MCSim |
Monte Carlo Simulation |
|
MoA |
Mode of action |
|
MoE |
Margin of exposure |
|
NAM |
New approach methodology |
|
NGRA |
Next generation risk assessment |
|
NLME |
Non-linear mixed effects |
|
NOAEL |
No-observed adverse effect level |
|
OECD |
Organisation for Economic Co-operation and Development |
|
PBPK |
Physiologically based pharmacokinetic modelling |
|
PFOA |
Perfluorooctanesulfonic acid |
|
PFOS |
Perfluorooctanoic acid |
|
PK |
Pharmacokinetics |
|
PLETHEM |
Population Life-course Exposure to Health Effects Model |
|
POD |
Point of departure |
|
QIVIVE |
Quantitative in vitro to in vivo extrapolation |
|
SA |
Sensitivity analysis |
|
SCCS |
Scientific Committee on Consumer Safety |
|
SME |
Small and medium-sized enterprises |
|
TK |
Toxicokinetics |
|
UA |
Uncertainty analysis |
|
US EPA |
United States Environmental Protection Agency |
|
US FDA |
United States Food and Drug Administration |
|
WHO |
World Health Organisation |